JPMorgan Chase & Co. disposed of 33.75 million shares of GENSCRIPT BIO (01548) off-exchange at an average of HKD 32.7394 per share on September 15, 2026, involving about HKD 1.10 billion. The transaction was an off-exchange cash consideration, not a direct secondary-market dealing.
Prior to the disposal, JPMorgan Chase & Co.'s long position in GENSCRIPT BIO was 162.39 million shares, representing 7.37%; following the disposal, the holding changed to 128.64 million shares, with the long position ratio falling to 5.64%.